Depression symptoms ‐ short term (end of treatment) · health problem or population
1 finding from 1 review
Depression remission · health problem or population
1 finding from 1 review
All‐cause mortality ‐ short term (end of treatment) · health problem or population
It is very uncertain whether summary of findings table ‐ Pharmacological treatment 1 changes all‐cause mortality ‐ short term (end of treatment) compared with pharmacological treatment 2 (very low certainty).
1 finding from 1 review
Cardiovascular mortality · health problem or population
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Myocardial infarction · health problem or population
1 finding from 1 review
Prolonged abstinence at longest · smokers with COPD
1 finding from 1 review
Point prevalence abstinence at longest · smokers with COPD
Pharmacological treatment probably leads to higher point prevalence abstinence at longest compared with a different pharmacological treatment (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · health problem or population
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Completion of treatment · management of opium withdrawal
It is very uncertain whether pharmacological detoxification treatment changes completion of treatment: baclofen versus clonidine compared with other pharmacological detoxification treatment (very low certainty).
4 findings from 1 review
RR 1.06 [0.63, 1.8]
66 participants
Very low
RR 2.01 [1.69, 2.38]
361 participants
Low
RR 0.95 [0.65, 1.37]
72 participants
Very low
Show 1 more finding
Completion of treatment: clonidine versus clonidine plus amantadine, inpatient setting · management of opium withdrawal
It is very uncertain whether pharmacological detoxification treatment changes completion of treatment: clonidine versus clonidine plus amantadine,… compared with other pharmacological detoxification treatment (very low certainty).
1 finding from 1 review
RR 1.03 [0.86, 1.24]
69 participants
Very low
Completion of treatment: clonidine versus buprenorphine, inpatient setting · management of opium withdrawal
It is very uncertain whether pharmacological detoxification treatment changes completion of treatment: clonidine versus buprenorphine, inpatient… compared with other pharmacological detoxification treatment (very low certainty).
1 finding from 1 review
RR 1.04 [0.9, 1.2]
35 participants
Very low
Completion of treatment: methadone versus methadone plus gabapentin · management of opium withdrawal
Pharmacological detoxification treatment showed no clear difference in completion of treatment: methadone versus methadone plus gabapentin compared with other pharmacological detoxification treatment (low certainty).
1 finding from 1 review
Individual symptom scores ‐ not measured · allergic rhinitis
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects ‐ epistaxis · allergic rhinitis
1 finding from 1 review
Health‐related quality of life (4 weeks to 6 months) · allergic rhinitis
1 finding from 1 review
Other adverse effects: local irritation · allergic rhinitis
1 finding from 1 review
Disease severity score (up to 4 weeks) · allergic rhinitis
1 finding from 1 review
Disease severity score (4 weeks to 6 months) · allergic rhinitis
1 finding from 1 review
Primary outcomes · infants at risk for, or having early symptoms consistent with, opioid withdrawal
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
– Modifying environmental stimulation · infants at risk for, or having early symptoms consistent with, opioid withdrawal
1 finding from 1 review